Cloobot Techlabs Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 398.31%
- Profit Growth 103.26%
- Ebitda 145.47%
- Net Worth 194.83%
- Total Assets 363.99%
About Cloobot Techlabs
Cloobot Techlabs Private Limited (CTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 August 2019 (Five years and five months 4 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Arumugam Balasubramanian, Tejasvin, Kesavan Vijayalakshmi, and One other member serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999TN2019PTC131349
-
Company No.
131349
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Cloobot Techlabs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tejasvin
|
Director | 29-Aug-2019 | Current |
|
Arumugam Balasubramanian
|
Director | 03-Jul-2021 | Current |
|
Kesavan Vijayalakshmi
|
Director | 10-Apr-2023 | Current |
|
Akshay Panse
|
Director | 10-Apr-2023 | Current |
Financial Performance of Cloobot Techlabs.
Cloobot Techlabs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 398.31% increase. The company also saw a substantial improvement in profitability, with a 103.26% increase in profit. The company's net worth Soared by an impressive increase of 194.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cloobot Techlabs?
In 2023, Cloobot Techlabs had a public holding of 33.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aigilx Health Technologies Private LimitedArumugam Balasubramanian is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cloobot Techlabs?
Unlock and access historical data on people associated with Cloobot Techlabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cloobot Techlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cloobot Techlabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
